For this one, I'll put a point of caution on it. It could be that you could negotiate these lower, or it could be that pharmacists may need to negotiate a higher fee in order to offset any other rebates they might have been receiving from the drug companies. On that one, we're not exactly sure about which way it would move.
On October 17th, 2017. See this statement in context.